| scholarly article | Q13442814 |
| P2093 | author name string | Yuji Morita | |
| Yoshiaki Kawamura | |||
| Junko Tomida | |||
| P2860 | cites work | Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1 | Q78666746 |
| NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli | Q24519031 | ||
| Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product | Q24542408 | ||
| An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli | Q24654765 | ||
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| Cathelicidins: family of antimicrobial peptides. A review | Q27027603 | ||
| MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor | Q28492463 | ||
| Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa | Q28492485 | ||
| An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa | Q28492570 | ||
| Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin | Q28492686 | ||
| Functional cloning and characterization of a multidrug efflux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant | Q28492688 | ||
| Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa | Q28492717 | ||
| Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase | Q28492833 | ||
| The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility | Q28492873 | ||
| Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS | Q28493107 | ||
| A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa | Q28493197 | ||
| Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1 | Q28493234 | ||
| Aminoglycoside antibiotics induce bacterial biofilm formation | Q28493241 | ||
| Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin | Q29346807 | ||
| Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein | Q33422951 | ||
| Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa | Q33982447 | ||
| Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa | Q34386310 | ||
| Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm | Q34408724 | ||
| Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. | Q34446329 | ||
| Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa | Q35065762 | ||
| Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
| Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa | Q35124489 | ||
| Antibiotics as intermicrobial signaling agents instead of weapons | Q35194014 | ||
| PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients | Q35598578 | ||
| PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients | Q35689189 | ||
| Resistance to beta-lactam antibiotics | Q35874928 | ||
| Aminoglycoside resistance in Pseudomonas aeruginosa | Q36021296 | ||
| Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa | Q36313190 | ||
| Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins | Q36314900 | ||
| MexXY multidrug efflux system of Pseudomonas aeruginosa | Q36450695 | ||
| Biotic acts of antibiotics | Q37101851 | ||
| Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. | Q37119379 | ||
| The type III secretion system of Pseudomonas aeruginosa: infection by injection | Q37397923 | ||
| Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa | Q37544527 | ||
| Antibiotic research in the age of omics: from expression profiles to interspecies communication | Q37935395 | ||
| Human host defense peptide LL-37 prevents bacterial biofilm formation | Q38289682 | ||
| PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. | Q38309969 | ||
| Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. | Q38626934 | ||
| Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa | Q39469881 | ||
| Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa | Q39475655 | ||
| MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa | Q39477726 | ||
| Mechanism of bactericidal action of aminoglycosides. | Q39675399 | ||
| Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. | Q39731888 | ||
| Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa | Q41781241 | ||
| Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa | Q41832678 | ||
| Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. | Q42072983 | ||
| mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol | Q42107628 | ||
| Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1. | Q42108051 | ||
| Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation | Q42111878 | ||
| Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa | Q42111886 | ||
| Translational control of the antibiotic inducibility of the PA5471 gene required for mexXY multidrug efflux gene expression in Pseudomonas aeruginosa | Q42112084 | ||
| Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin | Q42131963 | ||
| Application of an inducible system to engineer unmarked conditional mutants of essential genes of Pseudomonas aeruginosa | Q43032352 | ||
| Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants | Q43153453 | ||
| Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa | Q43189616 | ||
| Global transcriptomic response of Pseudomonas aeruginosa to chlorhexidine diacetate | Q43238770 | ||
| Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ. | Q43245264 | ||
| Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture | Q43264884 | ||
| The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms | Q43878593 | ||
| Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. | Q45991879 | ||
| Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability | Q47784438 | ||
| Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. | Q48052630 | ||
| Global transcriptional responses to triclosan exposure in Pseudomonas aeruginosa. | Q54304801 | ||
| Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates | Q61962375 | ||
| Long-term azithromycin may improve lung function in children with cystic fibrosis | Q74242408 | ||
| Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin | Q74630383 | ||
| Mechanisms of bacterial biocide and antibiotic resistance | Q78660493 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | 422 | |
| P577 | publication date | 2014-01-08 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Responses of Pseudomonas aeruginosa to antimicrobials | |
| P478 | volume | 4 |
| Q36888068 | A PhoPQ-Regulated ABC Transporter System Exports Tetracycline in Pseudomonas aeruginosa. |
| Q92993204 | A family of small, cyclic peptides buried in preproalbumin since the Eocene epoch |
| Q28492936 | Accumulation of Pyrimidine Intermediate Orotate Decreases Virulence Factor Production in Pseudomonas aeruginosa |
| Q35522004 | An ace up their sleeve: a transcriptomic approach exposes the AceI efflux protein of Acinetobacter baumannii and reveals the drug efflux potential hidden in many microbial pathogens |
| Q28816955 | Annona glabra Flavonoids Act As Antimicrobials by Binding to Pseudomonas aeruginosa Cell Walls |
| Q33627989 | Anti-Biofilm and Antivirulence Activities of Metabolites from Plectosphaerella cucumerina against Pseudomonas aeruginosa |
| Q40976300 | Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells |
| Q35101682 | Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii |
| Q57816209 | Antibiotic resistance: a rundown of a global crisis |
| Q41098639 | Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations |
| Q40652653 | Antimicrobial Activity of Tulsi (Ocimum tenuiflorum) Essential Oil and Their Major Constituents against Three Species of Bacteria |
| Q26752527 | Antimicrobial Drugs in Fighting against Antimicrobial Resistance |
| Q38938501 | Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients. |
| Q41507531 | Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa |
| Q36275773 | Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs |
| Q37154814 | Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa |
| Q49766082 | Berberine inhibits the MexXY-OprM efflux pump to reverse imipenem resistance in a clinical carbapenem-resistant Pseudomonas aeruginosa isolate in a planktonic state |
| Q92509055 | Bioactive Brominated Oxindole Alkaloids from the Red Sea Sponge Callyspongia siphonella |
| Q90070992 | Biological functions of nirS in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions |
| Q34071886 | Burn Patients Infected With Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa: Multidrug-Resistant Strains |
| Q90680968 | Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa |
| Q33645667 | Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens |
| Q38660817 | Chemical Composition and Antimicrobial Activities of the Essential Oil From Salvia mirzayanii Leaves |
| Q35030944 | Chloramphenicol and tetracycline decrease motility and increase invasion and attachment gene expression in specific isolates of multidrug-resistant Salmonella enterica serovar Typhimurium |
| Q47159376 | Colistin Resistance of Pseudomonas aeruginosa Isolated from Snakes in Taiwan. |
| Q42701999 | Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. |
| Q51039965 | Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa. |
| Q42773423 | Comparison of transcriptomes of wild-type and isothiazolone-resistant Pseudomonas aeruginosa by using RNA-seq |
| Q38279702 | Complete Genome Sequence Analysis of Pandoraea pnomenusa Type Strain DSM 16536(T) Isolated from a Cystic Fibrosis Patient |
| Q40508725 | Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation. |
| Q41147162 | Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus |
| Q52608900 | Drug resistance of oral bacteria to new antibacterial dental monomer dimethylaminohexadecyl methacrylate. |
| Q42089533 | Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics |
| Q39143538 | E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance |
| Q36835336 | Effects Due to Rhizospheric Soil Application of an Antagonistic Bacterial Endophyte on Native Bacterial Community and Its Survival in Soil: A Case Study with Pseudomonas aeruginosa from Banana |
| Q42731688 | Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. |
| Q38671076 | Efflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria. |
| Q34992258 | Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon |
| Q90230125 | Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling |
| Q35196247 | ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation. |
| Q40622669 | Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms. |
| Q57789664 | Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients |
| Q40056971 | Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain. |
| Q36346024 | Helicobacter pylori Resists the Antimicrobial Activity of Calprotectin via Lipid A Modification and Associated Biofilm Formation |
| Q92218720 | Immediate effect of pulsed high-intensity neodymium-doped yttrium aluminum garnet (Nd: YAG) laser on staphylococcus aureus and pseudomonas aeruginosa growth: an experimental study |
| Q94525083 | In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens |
| Q51559665 | In vitro antimicrobial activity of a gel containing antimicrobial peptide AMP2041, chlorhexidine digluconate and Tris-EDTA on clinical isolates of Pseudomonas aeruginosa from canine otitis. |
| Q91613917 | In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa |
| Q37697412 | In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics |
| Q46516620 | Integron occurrence is linked to reduced biocide susceptibility in multidrug resistant Pseudomonas aeruginosa |
| Q35830489 | Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa |
| Q38214155 | Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa |
| Q34159099 | Low-dose antibiotics: current status and outlook for the future |
| Q89302995 | Mechanisms of RsaL mediated tolerance to ciprofloxacin and carbenicillin in Pseudomonas aeruginosa |
| Q29346770 | Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product |
| Q89883834 | Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa |
| Q38367630 | Mutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics |
| Q53702253 | Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam. |
| Q40936407 | NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection. |
| Q40267452 | Nanosilver induces a non-culturable but metabolically active state in Pseudomonas aeruginosa |
| Q92514640 | Non-invasive, ratiometric determination of intracellular pH in Pseudomonas species using a novel genetically encoded indicator |
| Q37421175 | Otopathogenic Pseudomonas aeruginosa Enters and Survives Inside Macrophages |
| Q37619970 | Outer Membrane Proteins form Specific Patterns in Antibiotic-Resistant Edwardsiella tarda |
| Q29346778 | PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa |
| Q50083255 | PA5470 Counteracts Antimicrobial Effect of Azithromycin by Releasing Stalled Ribosome in Pseudomonas aeruginosa. |
| Q28551861 | Polyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In Vitro |
| Q47237314 | PqsA Promotes Pyoverdine Production via Biofilm Formation. |
| Q92580938 | Proanthocyanidin Interferes with Intrinsic Antibiotic Resistance Mechanisms of Gram-Negative Bacteria |
| Q41476533 | Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study |
| Q37503911 | Pseudomonas aeruginosa Enolase Influences Bacterial Tolerance to Oxidative Stresses and Virulence |
| Q40819027 | Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa |
| Q64061094 | Resistance Toward Chlorhexidine in Oral Bacteria - Is There Cause for Concern? |
| Q42689550 | Role of inducers in detection of blaPDC-mediated oxyimino-cephalosporin resistance in Pseudomonas aeruginosa. |
| Q41881737 | RpoN Promotes Pseudomonas aeruginosa Survival in the Presence of Tobramycin |
| Q40883169 | Selection of Single-Stranded DNA Molecular Recognition Elements against Exotoxin A Using a Novel Decoy-SELEX Method and Sensitive Detection of Exotoxin A in Human Serum |
| Q38183671 | Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa |
| Q90236429 | Sodium houttuyfonate in vitro inhibits biofilm dispersion and expression of bdlA in Pseudomonas aeruginosa |
| Q47438121 | Synergistic effects of heat and antibiotics on Pseudomonas aeruginosa biofilms |
| Q28547167 | Synthesis and evaluation of chloramphenicol homodimers: molecular target, antimicrobial activity, and toxicity against human cells |
| Q87038695 | Taurine Haloamines and Biofilm. Part I: Antimicrobial Activity of Taurine Bromamine and Chlorhexidine Against Biofilm Forming Pseudomonas aeruginosa |
| Q26786956 | The Three Bacterial Lines of Defense against Antimicrobial Agents |
| Q46812029 | The concentration-determined and population-specific antimicrobial effects of free nitrous acid on Pseudomonas aeruginosa PAO1. |
| Q40090439 | The diagnosis and management of contact lens-related microbial keratitis |
| Q38646943 | Understanding the mechanisms and drivers of antimicrobial resistance. |
| Q35105960 | Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa |
| Q40137469 | Use of Single-Frequency Impedance Spectroscopy to Characterize the Growth Dynamics of Biofilm Formation in Pseudomonas aeruginosa |
| Q93170448 | Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa |
| Q61444724 | Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa |
Search more.